机构：[1]Department of Pathology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China医技科室病理科河北医科大学第四医院[2]Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China[3]Department of Pathology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[4]Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China医技科室病理科河北医科大学第四医院[5]Shuwen Biotech Co. Ltd., Hangzhou, China
第一作者机构：[1]Department of Pathology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
推荐引用方式(GB/T 7714)：
Liu Yueping,Lv Hong,Shen Mengjia,et al.ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis[J].JOURNAL OF CLINICAL ONCOLOGY.2023,41(16):
APA：
Liu, Yueping,Lv, Hong,Shen, Mengjia,Shui, Ruohong,Ye, Feng...&Bu, Hong.(2023).ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis.JOURNAL OF CLINICAL ONCOLOGY,41,(16)
MLA：
Liu, Yueping,et al."ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis".JOURNAL OF CLINICAL ONCOLOGY 41..16(2023)
医学